Blacksmith Medicines
David Puerta Ph.D., COO and VP of Discovery & co-founder of Blacksmith Medicines and Forge Therapeutics. Previously, David led discovery at Living Proof (acquired by Unilever) where he helped discover and develop new chemistry technologies for consumer products. He received a BA in Chemistry from California State University Dominguez Hills and while earning a Ph.D. in Chemistry & Biochemistry from UCSD he helped develop the metalloenzyme technology platform.
This person is not in any offices
Blacksmith Medicines
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.